A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis

Journal of Vascular Surgery

Volumn 23, Issue 1, 1996, Pages 36-45

  Levy, P J ^a   Gonzalez, M F ^a   Hornung, C A ^a   Chang, W W ^a   Haynes, J L ^a   Rush, D S ^a   Donaldson, M C ^a   Brantigan, C O ^a   Eastcott, H H G ^a   Cohen, E A ^a   Risberg, B ^a   Kasprzan, P M ^a  

^a Two Medical Park   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ATHEROGENESIS; ATHEROSCLEROSIS; CONFERENCE PAPER; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; LEG ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; REVASCULARIZATION; RISK FACTOR;

EID: 0030051993     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(05)80033-3     Document Type: Conference Paper

References (29)

1. McCready RA Vincent AE Schwartz RW Hyde GL Mattingly SS Griffen WO Jr. Atherosclerosis in the young: a virulent disease Surgery 96 1984 863 868
2. Pairolero BC Joyce JW Skinner CR Hollier LH Cherry KJ Lower limb ischemia in young adults: prognostic implications J Vasc Surg 1 1984 459 464
3. Hallett JW Greenwood LH Robison JG Lower extremity arterial disease in young adults: a systemic approach to early diagnosis Ann Surg 202 1985 647 652
4. Valentine RJ MacGillivray DC DeNobile JW Snyder DA Rich NM Intermittent claudication caused by atherosclerosis in patients aged forty years and younger Surgery 107 1990 560 565
5. Levy PJ Hornung CA Haynes JL Rush DS Lower extremity ischemia in adults younger than 40 years of age: a community-wide survey of premature atherosclerotic arterial disease J Vasc Surg 19 1994 873 881
6. Eldrup-Jorgensen EJ Flanigan P Brace L Hypercoagulable states and lower limb ischemia in young adults J Vasc Surg 9 1989 334 341
7. Aronson DC Ruys T van Bockel JH A prospective survey of risk factors in young adults with arterial occlusive disease Eur J Vasc Surg 3 1989 227 232
8. Valentine RJ Kaplan HS Green R Jacobsen DW Myers SI Clagett GP Lipoprotien (a), homocystine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis J Vasc Surg 23 1996 53 63
9. Donaldson MC Weinburg DS Belkin M Whittemore AD Mannick JA Screening for hypercoagulable states in vascular surgical practice J Vasc Surg 11 1990 825 831
10. Tollefson DJF Friedman KD Marlar RA Bandyk DF Towne JB Protein C deficiency: a cause of unusual or unexplained thrombosis Arch Surg 123 1988 881 884
11. Eason JD Mills JL Beckett WC Hypercoagulable states in arterial thromboembolism Surg Gynecol Obstet 174 1992 211 215
12. Levy PJ Gonzalez FM Rush DS Haynes JL Hypercoagulable states as an evolving risk for spontaneous venous and arterial thrombosis J Amer Coll Surg 178 1994 266 270
13. Rader DJ Brewer HB Lipoprotein (a): clinical approach to a unique atherogenic lipoprotein JAMA 267 1992 1109 1112
14. Valentine RJ Grayburn PA Vega GL Grundy SM Lp(a) lipoprotein is an independent discriminating risk factor for premature peripheral atherosclerosis among white men Arch Intern Med 154 1994 801 806
15. Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery Suggested standards for reports dealing with lower extremity ischemia J Vasc Surg 4 1986 80 84
16. Abildgaard U Lie M Odegard OR Antithrombin assay with new chromogenic substrates (S-2238 and Chromozyn TH) Thromb Res 11 1977 549 553
17. Tollefsen DM Majerus DW Blank MK Heparin cofactor II: purification and properties of a heparin dependent inhibitor of thrombin in human plasma J Biol Chem 257 1982 2162 2169
18. Esmon CT Protein C: biochemistry, physiology and clinical implications Blood 62 1983 1155 1158
19. Suzuki K Nishioka J Plasma protein S activity measurement using Protac, a snake venom derived activator of protein C Thromb Res 49 1988 241 251
20. Avvisati G ten Cate JW van Wijk EM Kahle LH Mariani G Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant treatment Br J Hematol 45 1980 343 352
21. Falkon L Gari IM Borrel M Fontcuberta J The release of plasminogen activators (t-PA and U-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis Blood Coag Fibrinolysis 3 1992 33 38
22. Edelberg JM Gonzalez GM Pizzo SU Lipoprotein (a) inhibits streptokinase mediated activation of human plasminogen Biochemistry 28 1989 2370 2374
23. Harris EN Boeg ML MacKnorth-Young CG Anticardiolipin antibodies: detection by ELISA and association with thrombosis in systemic lupus erythematosus Lancet 2 1983 1211 1213
24. Gladson CL Schaarer I Hach V Beck KH Griffin JH The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young adults with venous thrombosis Thromb Haemost 59 1988 18 22
25. Allaart CF Aronson DC Ruys T Hereditary protein S deficiency in young adults with arterial occlusive disease Thromb Haemost 64 1990 206 210
26. Dawson S Henny A The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review Atherosclerosis 95 1992 105 107
27. Earnshaw JJ Westby JC Makin GS Hopkinson BR Defective fibrinolysis: a risk factor in early femoropopliteal graft thrombosis Br J Surg 4 1987 932 935
28. Schneiderman J Eguchi Y Adar R Sawdey M Modulation of fibrinolytic system by major peripheral ischemia J Vasc Surg 19 1994 516 524
29. McDaniel MD Pearce WH Yao JST Sequential changes in coagulation and platelet function following femorotibial bypass J Vasc Surg 1 1984 261 268